Investigation of de novo mutations in a schizophrenia case-parent trio by induced pluripotent stem cell-based in vitro disease modeling: convergence of schizophrenia- and autism-related cellular phenotypes
Autor: | Boróka Czehlár, László Homolya, Zsofia Nemoda, Júlia Koller, Nóra Varga, Eszter Szabó, Bálint Jezsó, Mária Judit Molnár, Csongor Tordai, János Réthelyi, Máté Baradits, Ágota Apáti, Laszlo Nagy, Zsuzsa Erdei, Edit Hathy |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
0301 basic medicine Sialoglycoproteins Autism Induced Pluripotent Stem Cells Proliferation Medicine (miscellaneous) Biology RNASeq Biochemistry Genetics and Molecular Biology (miscellaneous) lcsh:Biochemistry Transcriptome 03 medical and health sciences 0302 clinical medicine Humans lcsh:QD415-436 KHSRP Autistic Disorder Progenitor cell Induced pluripotent stem cell lcsh:R5-920 iPSC Research Dentate gyrus Wnt signaling pathway RNA-Binding Proteins Cell Biology Phenotype 030104 developmental biology LRRC7 Mutation Leukocytes Mononuclear Schizophrenia Trans-Activators Molecular Medicine Glutamate Mitochondrial function Stem cell lcsh:Medicine (General) Disease-modeling Reprogramming Neuroscience DNM 030217 neurology & neurosurgery |
Zdroj: | Stem Cell Research & Therapy Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-15 (2020) |
ISSN: | 1757-6512 |
DOI: | 10.1186/s13287-020-01980-5 |
Popis: | Background De novo mutations (DNMs) have been implicated in the etiology of schizophrenia (SZ), a chronic debilitating psychiatric disorder characterized by hallucinations, delusions, cognitive dysfunction, and decreased community functioning. Several DNMs have been identified by examining SZ cases and their unaffected parents; however, in most cases, the biological significance of these mutations remains elusive. To overcome this limitation, we have developed an approach of using induced pluripotent stem cell (iPSC) lines from each member of a SZ case-parent trio, in order to investigate the effects of DNMs in cellular progenies of interest, particularly in dentate gyrus neuronal progenitors. Methods We identified a male SZ patient characterized by early disease onset and negative symptoms, who is a carrier of 3 non-synonymous DNMs in genes LRRC7, KHSRP, and KIR2DL1. iPSC lines were generated from his and his parents’ peripheral blood mononuclear cells using Sendai virus-based reprogramming and differentiated into neuronal progenitor cells (NPCs) and hippocampal dentate gyrus granule cells. We used RNASeq to explore transcriptomic differences and calcium (Ca2+) imaging, cell proliferation, migration, oxidative stress, and mitochondrial assays to characterize the investigated NPC lines. Results NPCs derived from the SZ patient exhibited transcriptomic differences related to Wnt signaling, neuronal differentiation, axonal guidance and synaptic function, and decreased Ca2+ reactivity to glutamate. Moreover, we could observe increased cellular proliferation and alterations in mitochondrial quantity and morphology. Conclusions The approach of reprograming case-parent trios represents an opportunity for investigating the molecular effects of disease-causing mutations and comparing these in cell lines with reduced variation in genetic background. Our results are indicative of a partial overlap between schizophrenia and autism-related phenotypes in the investigated family. Limitations Our study investigated only one family; therefore, the generalizability of findings is limited. We could not derive iPSCs from two other siblings to test for possible genetic effects in the family that are not driven by DNMs. The transcriptomic and functional assays were limited to the NPC stage, although these variables should also be investigated at the mature neuronal stage. |
Databáze: | OpenAIRE |
Externí odkaz: |